West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$390.30−6.39 (-1.61%)
Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%
West Pharmaceutical Services gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
West Pharmaceutical Services's gross profit for the twelve months ending Sep 30, 2026 was $1.28B, up 18.9% year over year. For fiscal 2025 it was $1.10B, up 10.6% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $1.18B in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | +10.6% |
| FY2024 | Dec 31, 2024 | $998.50M | -11.6% |
| FY2023 | Dec 31, 2023 | $1.13B | -0.6% |
| FY2022 | Dec 31, 2022 | $1.14B | -3.4% |
| FY2021 | Dec 31, 2021 | $1.18B | +53.1% |
| FY2020 | Dec 31, 2020 | $767.80M | +26.8% |
| FY2019 | Dec 31, 2019 | $605.70M | +11.1% |
| FY2018 | Dec 31, 2018 | $545.40M | +6.3% |
| FY2017 | Dec 31, 2017 | $512.90M | +2.3% |
| FY2016 | Dec 31, 2016 | $501.40M | +10.0% |
| FY2015 | Dec 31, 2015 | $455.80M | +1.8% |
| FY2014 | Dec 31, 2014 | $447.80M | +3.0% |
| FY2013 | Dec 31, 2013 | $434.70M | +12.1% |
| FY2012 | Dec 31, 2012 | $387.70M | +14.3% |
| FY2011 | Dec 31, 2011 | $339.30M | +6.7% |
| FY2010 | Dec 31, 2010 | $318.10M | +4.8% |
| FY2009 | Dec 31, 2009 | $303.60M | +0.3% |
| FY2008 | Dec 31, 2008 | $302.60M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $347.40M | +18.0% |
| Q2 FY2026 | Jun 30, 2026 | $329.20M | +20.2% |
| Q1 FY2026 | Mar 31, 2026 | $296.40M | +27.8% |
| Q4 FY2025 | Dec 31, 2025 | $303.90M | +11.1% |
| Q3 FY2025 | Sep 30, 2025 | $294.30M | +11.2% |
| Q2 FY2025 | Jun 30, 2025 | $273.90M | +19.1% |
| Q1 FY2025 | Mar 31, 2025 | $231.90M | +0.7% |
| Q4 FY2024 | Dec 31, 2024 | $273.60M | -1.7% |
| Q3 FY2024 | Sep 30, 2024 | $264.70M | -8.2% |
| Q2 FY2024 | Jun 30, 2024 | $230.00M | -21.1% |
| Q1 FY2024 | Mar 31, 2024 | $230.20M | -15.1% |
| Q4 FY2023 | Dec 31, 2023 | $278.20M | +6.1% |
| Q3 FY2023 | Sep 30, 2023 | $288.30M | +7.6% |
| Q2 FY2023 | Jun 30, 2023 | $291.40M | -9.4% |
| Q1 FY2023 | Mar 31, 2023 | $271.30M | -4.7% |
| Q4 FY2022 | Dec 31, 2022 | $262.10M | -12.8% |
| Q3 FY2022 | Sep 30, 2022 | $268.00M | -7.0% |
| Q2 FY2022 | Jun 30, 2022 | $321.50M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | $284.60M | +4.7% |
| Q4 FY2021 | Dec 31, 2021 | $300.60M | +42.4% |
| Q3 FY2021 | Sep 30, 2021 | $288.20M | +48.1% |
| Q2 FY2021 | Jun 30, 2021 | $315.10M | +61.5% |
| Q1 FY2021 | Mar 31, 2021 | $271.90M | +62.8% |
| Q4 FY2020 | Dec 31, 2020 | $211.10M | +37.8% |
| Q3 FY2020 | Sep 30, 2020 | $194.60M | +31.7% |
| Q2 FY2020 | Jun 30, 2020 | $195.10M | +23.6% |
| Q1 FY2020 | Mar 31, 2020 | $167.00M | +13.8% |
| Q4 FY2019 | Dec 31, 2019 | $153.20M | +15.0% |
| Q3 FY2019 | Sep 30, 2019 | $147.80M | +9.0% |
| Q2 FY2019 | Jun 30, 2019 | $157.90M | +11.0% |
| Q1 FY2019 | Mar 31, 2019 | $146.80M | +9.2% |
| Q4 FY2018 | Dec 31, 2018 | $133.20M | +3.6% |
| Q3 FY2018 | Sep 30, 2018 | $135.60M | +8.4% |
| Q2 FY2018 | Jun 30, 2018 | $142.20M | +13.8% |
| Q1 FY2018 | Mar 31, 2018 | $134.40M | +0.1% |
| Q4 FY2017 | Dec 31, 2017 | $128.60M | +4.0% |
| Q3 FY2017 | Sep 30, 2017 | $125.10M | – |
| Q2 FY2017 | Jun 30, 2017 | $125.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $134.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $123.70M | – |
See a number that looks wrong?